RenovoRx RNXT 深 滬
等待開盤 10-27 09:30:00 美东时间
1.18
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.18
- 總市值 4324.22万
- 52周最高 1.6899
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.75
- 委 比 0.00%
- 總股本 3664.59万
- 歷史最高 16.74
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.5306
- 每 手 1
- 風險率 0.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – MIT and Harvard scientists recently created...
10-17 21:50
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
<p>RenovoRx, Inc. 宣布聘请著名介入肿瘤学家 Thierry de Baère 教授加入其科学顾问委员会。De Baère 教授在局部区域癌症治疗领域拥有丰富经验，其专长与 RenovoRx 的 TAMP™ 技术平台高度契合。TAMP 技术通过 RenovoCath 设备实现靶向药物递送，旨在优化肿瘤治疗效果并减少系统毒性。RenovoRx 正在推进 TAMP 技术的临床试验，并致力于将其应用于更多商业机会。</p>
10-09 12:30
RenovoRx Completes First Registry-Eligible Patient Procedure In PanTheR Post-Marketing Registry Study At University Of Vermont Cancer Center
First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer CenterBaptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of Vermont Cancer Center
09-25 20:32
RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites
The first registry-eligible patient procedure in RenovoRx's PanTheR Post-Marketing Registry Study was completed at the University of Vermont Cancer Center. Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center have joined the study. The PanTheR registry aims to gather real-world safety and performance data of the FDA-cleared RenovoCath device for solid tumor patients. RenovoRx plans to expand patient enrollment and tre...
09-25 12:30
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
RenovoRx CEO Shaun Bagai will present at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16-17, discussing the company's commercialization of RenovoCath and its Phase III TIGeR-PaC clinical trial for pancreatic cancer treatment. Bagai will highlight the trial's progress and the Data Monitoring Committee's recommendation to continue the study following the second interim analysis. The presentation will also cover ...
09-11 12:30
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge
Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.
09-08 17:59
SRx Health Solutions Signed a Letter of Intent to Acquire the Assets of Royal Uranium
SRx Health Solutions, Inc. has signed a non-binding Letter of Intent to acquire 100% of Royal Uranium Inc.'s assets, expanding its mission to combine hard-asset energy royalties amid surging AI and data center power demand. The deal, subject to customary closing conditions, includes 18 uranium royalties across key jurisdictions. The acquisition aims to capitalize on global clean energy transition and growing demand for nuclear energy, with strate...
08-18 11:00
RenovoRx Announces The Independent Data Monitoring Committee For Its Ongoing Phase III TIGeR-PaC Trial Has Recommended To Continue The Study
"At the same time, we are very excited to report that the independent Data Monitoring Committee (DMC) for our ongoing Phase III TIGeR-PaC trial recently completed their review of our second pre-planned interim analysis
08-15 04:18
RenovoRx Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $422.00K Beat $329.67K Estimate
RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 8.05 percent. This is a 20 percent increase over losses of $(0.10) per share from the same
08-15 04:12
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
